Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881712 · ClinicalTrials.gov registry record · NA
Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00881712 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 15 participants.
The verdict
NCT00881712, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what effects, good and/or bad, proton radiation at a higher tumor dose (and lower normal surrounding lung dose) combined with standard chemotherapy has on lung cancer. The dose you receive to the tumor will be higher than the standard dose. This may be able to increase the control of the tumor. Due to the accuracy of radiation given with protons, the dose to the normal lung tissue that surrounds the tumor will be lower than standard. This may be able to reduce the frequency and severity of the usual radiation side effects.
Interventions
- RADIATION PET positive nodal disease measuring 15 mm or greater
- RADIATION PET positive nodal disease measuring less than 15 mm
- RADIATION Patients considered resectable
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00881712
The ClinicalTrials.gov registry entry for NCT00881712 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PET positive nodal disease measuring 15 mm or greater is the first listed.
NCT00881712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00881712 about?
NCT00881712 is a clinical study titled "Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)". The purpose of this study is to find out what effects, good and/or bad, proton radiation at a higher tumor dose (and lower normal surrounding lung dose) combined with standard chemotherapy has on lung cancer. The dose you receive to the tumor will be higher than the standard dose. This may be able t...
What is the current status of trial NCT00881712?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2009-06. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00881712?
The interventions under investigation include: PET positive nodal disease measuring 15 mm or greater (RADIATION), PET positive nodal disease measuring less than 15 mm (RADIATION), Patients considered resectable (RADIATION).
Who is sponsoring clinical trial NCT00881712?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.